TAKEDA PHARMACEUTICAL CO LTD
13F Reported Value
ⓘ$16.4M
Holdings
8
Latest Filing
2025-09-30
Filing Quarter
Q3 2025
Portfolio Overview
TAKEDA PHARMACEUTICAL CO LTD disclosed 8 positions worth $16.4M in its Form 13F-HR for Q3 2025, led by $OVID (Ovid Therapeutics Inc.) at 59.8% of the equity portfolio, followed by $EQ. During the quarter the fund opened 0 new positions and exited 3. The portfolio is most concentrated in Healthcare (89.3% of disclosed assets). All figures are sourced directly from TAKEDA PHARMACEUTICAL CO LTD’s Form 13F-HR filing with the SEC under CIK 1395064.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q3 2025
Click any card to unlockTop Holdings
- 13.1#2,772
Quality
$9.8M7,531,996 sh - 27.2#2,473
Quality
$2.6M1,824,977 sh Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)
—Quality
$1.2M1,475,121 sh- —
Quality
$1.2M515,619 sh - 3.6
Quality
$891.4K54,887 sh - 24.2
Quality
$478.1K77,733 sh - $101.6K203,190 sh
- 38.8
Quality
$21.5K16,515 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Ovid Therapeutics Inc.$OVID | 13.1#2,772 | $9.8M | 7,531,996 |
 Equillium, Inc.$EQ | 27.2#2,473 | $2.6M | 1,824,977 |
| Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | — | $1.2M | 1,475,121 |
 Shattuck Labs, Inc.$STTK | — | $1.2M | 515,619 |
 Lyell Immunopharma, Inc.$LYEL | 3.6 | $891.4K | 54,887 |
 American Well Corp$AMWL | 24.2 | $478.1K | 77,733 |
 Rani Therapeutics Holdings, Inc.$RANI | — | $101.6K | 203,190 |
 STANDARD BIOTOOLS INC.$LAB | 38.8 | $21.5K | 16,515 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of TAKEDA PHARMACEUTICAL CO LTD's 8 positions.
Showing top 8 of 8 holdings.
Sector Allocation
Healthcare
$14.6M
Other
$1.2M
Industrials
$478,061
Technology
$21,470
Full Holdings — TAKEDA PHARMACEUTICAL CO LTD (Q3 2025)
All 8 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $OVID | Ovid Therapeutics Inc. | $9.8M | 59.8% | +0% | 13.1 |
| 2 | $EQ | Equillium, Inc. | $2.6M | 15.9% | +0% | 27.2 |
| 3 | — | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | $1.2M | 7.6% | +0% | — |
| 4 | $STTK | Shattuck Labs, Inc. | $1.2M | 7.5% | +0% | — |
| 5 | $LYEL | Lyell Immunopharma, Inc. | $891,365 | 5.5% | +33% | 3.6 |
| 6 | $AMWL | American Well Corp | $478,061 | 2.9% | +0% | 24.2 |
| 7 | $RANI | Rani Therapeutics Holdings, Inc. | $101,554 | 0.6% | +0% | — |
| 8 | $LAB | STANDARD BIOTOOLS INC. | $21,470 | 0.1% | +0% | 38.8 |
Exited Positions (3)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for TAKEDA PHARMACEUTICAL CO LTD including:
Track TAKEDA PHARMACEUTICAL CO LTD's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for TAKEDA PHARMACEUTICAL CO LTD and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: TAKEDA PHARMACEUTICAL CO LTD
13F Pro is an AI hedge fund tracker and stock research platform. For TAKEDA PHARMACEUTICAL CO LTD (SEC CIK: 1395064), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in TAKEDA PHARMACEUTICAL CO LTD's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.